BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/18/2016 3:13:00 PM | Browse: 1305 | Download: 3140
 |
Received |
|
2016-07-11 09:24 |
|
Peer-Review Started |
|
2016-07-13 15:52 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-08-24 18:35 |
|
Revised |
|
2016-09-18 22:17 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-09-30 10:51 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-10-10 17:16 |
|
Articles in Press |
|
2016-10-10 17:16 |
|
Edit the Manuscript by Language Editor |
|
2016-10-16 12:33 |
|
Typeset the Manuscript |
|
2016-11-12 13:44 |
|
Publish the Manuscript Online |
|
2016-11-18 15:13 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Allergy |
| Manuscript Type |
Retrospective Study |
| Article Title |
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Da-Wu Zeng, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu and Yu-Rui Liu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Youth Foundation of the Health and Family Planning Commission of Fujian Province |
2014-1-55 |
|
| Corresponding Author |
Yue-Yong Zhu, MD, Liver Center, The First Affiliated Hospital, Fujian Medical University, No. 20 Chazhong Road, Taijiang District, Fuzhou 350005, Fujian Province, China. ezhu066@sina.com
|
| Key Words |
Chronic hepatitis B; Liver biopsy; Fibrosis; Cirrhosis; Ceruloplasmin |
| Core Tip |
To date, few non-invasive approaches have been developed to evaluate liver fibrosis and no studies have proposed measuring ceruloplasmin (CP) levels for predicting liver fibrosis in chronic hepatitis B (CHB) virus patients with normal or minimally raised alanine aminotransferase (ALT). This study showed CP was independently and negatively associated with liver fibrosis. Furthermore, a simple and accurate CG model was developed to predict significant liver fibrosis and cirrhosis in CHB patients with normal or mildly elevated ALT. This model may be a valuable tool to replace liver biopsy in this category of hepatitis B virus-infected patients.
|
| Publish Date |
2016-11-18 15:13 |
| Citation |
Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i43.9586 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
